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Background. Many biological processes are characterized by allometric relations of the type Y=Y0M
b between an observable
Y and body mass M, which pervade at multiple levels of organization. In what regards the hematopoietic stem cell pool, there
is experimental evidence that the size of the hematopoietic stem cell pool is conserved in mammals. However, demands for
blood cell formation vary across mammals and thus the size of the active stem cell compartment could vary across species.
Methodology/Principle Findings. Here we investigate the allometric scaling of the hematopoietic system in a large group of
mammalian species using reticulocyte counts as a marker of the active stem cell pool. Our model predicts that the total
number of active stem cells, in an adult mammal, scales with body mass with the exponent L. Conclusion/Significance. The
scaling predicted here provides an intuitive justification of the Hayflick hypothesis and supports the current view of a small
active stem cell pool supported by a large, quiescent reserve. The present scaling shows excellent agreement with the
available (indirect) data for smaller mammals. The small size of the active stem cell pool enhances the role of stochastic effects
in the overall dynamics of the hematopoietic system.
Citation: Dingli D, Pacheco JM (2006) Allometric Scaling of the Active Hematopoietic Stem Cell Pool across Mammals. PLoS ONE 1(1): e2. DOI: 10.1371/
journal.pone.0000002
INTRODUCTION
Scaling, in physics, has provided fundamental insights from the
tiny quark to the universe at large. In biology, allometric scaling
[1] is typically associated with a simple power law: Y=Y0M
b,
where Y is some observable and M is the mass of the organism.
Allometric scaling has been identified on a wide range of
observables [2–5], from basal metabolic rate (BMR), heart rate,
aortic and tree trunk radii, to unicellular genome lengths.
Intriguingly, most of the scaling exponents b are multiples of the
power
1/4, and the origin of this general dependence has been
subjected to intense investigation. A beautiful explanation was
proposed by West et al. [4], where the
3/4 exponent in BMR
scaling was related to a surface to volume ratio in a four-
dimensional biological world. Although other explanations have
been proposed [6], the
3/4 scaling has been challenged [7,8] and
plants have recently been found to scale differently [9], allometric
scaling remains ubiquitous in biology, and has provided novel
insights on various biological processes.
Blood is also ubiquitous, and has been the subject of
investigation for centuries. Our present understanding of the
hematopoietic system has improved tremendously since William
Harvey described the circulatory system in the 17
th century.
Indeed, our current understanding relies on the concept of stem
cells [10–15]. This view identifies the bone marrow as the site of
active cell replication, responsible for the maintenance of the
circulating blood cell pool that is continuously undergoing
apoptotic senescence. Blood cell production is maintained by
hematopoietic stem cells that have the capacity to both self-renew
and differentiate into all types of blood cells [12] (see Figure 1).
The number of hematopoietic stem cells has been estimated in
various species using indirect methods. These include the SCID
repopulating cell (SRC) assay [16], rescue of lethally irradiated
mice and rats using serial dilutions of bone marrow derived cells
[17,18] and ferrokinetic studies that estimate red blood cell
production and correlate this with total marrow cellularity and the
myeloid to erythroid ratio [19].
Perhaps rather surprisingly, Abkowitz et al. [19] recently
suggested that the total number of hematopoietic stem cells is
conserved from mouse to humans, and proposed that this may
apply to all mammals. They estimated that mammals have between
11000 and 22000 hematopoietic stem cells. Subsequent studies in
Rattus norvegicus were consistent with this prediction [18]. There is
indirect evidence to suggest that this may also be true in elephants,
whose African variant may reach a mass of approximately 6000 kg
[20]. However, the demands for blood cell production vary across
species: the number of cells produced by a murine bone marrow
over the life-time of a mouse is equal to what a human bone
marrow produces in a day or a cat in a week [21].
Potential mechanisms that can explain these different pro-
duction rates include (i) an active stem cell pool that varies with
animal size, (ii) faster rates of replication as the size of the species
increases, (iii) longer cell specific contribution to hematopoiesis
and (iv) a number of committed cell lineages that produce
terminally differentiated blood cells which increases with animal
size (Figure 1), with none of these mechanisms being mutually
exclusive.
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two functionally distinct compartments [22]: a quiescent, reserve
pool where cells divide rarely, and another pool of actively
replicating cells that contribute to hematopoiesis for some time to
be replaced by cells from the reserve pool. Since the demands for
blood cell production vary across species [17–19,21], it is possible
that the active stem cell pool scales allometrically with adult mass
despite the fact that the total number of stem cells may be
conserved across mammalian species [19].
Potential explanations (i) and (ii) relate the hematopoietic system
with animal size. Basal metabolism is clearly related to the
hematopoietic system since hemoglobin, exclusively transported by
red blood cells, is the main carrier of oxygen throughout the
organism, thereby ensuring an adequate supply for metabolic
needs. Consequently, it is natural to assume the existence of
allometric scaling in the hematopoietic system, a feature which
may prove insightful in determining the size and properties of the
stem-cell pool.
In the following, we make use of allometric scaling to estimate
the number of active stem cells contributing to hematopoiesis in
adult mammals from voles to elephants.
Allometric scaling of the active stem-cell pool
As is well known, blood volume is a function of animal mass [23].
Furthermore, rates of cell production in an animal should scale,
under normal conditions, with the species specific BMR [3]. The
specific BMR -RM- has been shown to scale as RM,M
21/4 across
27 orders of magnitude, from the sub-cellular respiratory
complexes to unicellular organisms up to the largest mammals
[3]. If red blood cells of a given animal originate from NSC active
stem cells, then we may expect that, per unit time, the number of
red blood cells produced will scale as NSCRM. During hematopoi-
esis, stem cells divide and as the daughter cells become more
differentiated, they progressively lose their ability to replicate.
However, during replication the number of cells produced from
one stem cell increases exponentially at an ideal rate of 2
k, where k
represents the number of distinct replication steps before the cell
loses the ability to divide (Figure 1). Here we assume that the
process exhibits the same efficiency across species and as such
contributes with a constant factor to red blood cell production.
Red blood cell production is best evaluated by measuring the total
number of circulating reticulocytes (RT) in a given species. Indeed,
estimating blood production based on red blood cell survival may be
misleading, since many extrinsic factors contribute to premature
red blood cell destruction, and these can be difficult to quantify
[24]. On the other hand, circulating reticulocytes, precursors of
red blood cells, should reflect more accurately blood production
originating from the active stem cell pool. Consequently, we
predict that reticulocyte production per day (RTD) scales as
RTD,NSCRM.
RTD can be obtained by dividing RT by the time required for
reticulocyte maturation, t. In other words, RTD,RTt
21,RTRM
since, under normal conditions, the specific BMR RM ultimately
determines maturation time [25]. Equating the two expressions for
RTD allows us to predict that NSC,RT. Therefore, we can deduce
the allometric scaling of the active stem cell pool in the animal’s
bone marrow from the corresponding scaling of the total
reticulocyte count across species. In Materials and Methods we
describe how we collected data for RT from mammalian species, as
well as the procedure used to determine its allometric exponent.
RESULTS AND DISCUSSION
By fitting the data collected for reticulocyte count across different
mammalian species in the way described in the Materials and
Methods section, we obtained a L power law- scaling for the
mass-dependence of the size of the active stem-cell pool,
NSC*M
3=4. Using the well-studied cat data [26] as a reference,
which estimates the size of the active stem cell pool as NSC=13
after a stem cell transplant, the allometric relation above predicts
that NSC=111 in humans (mass = 70 kg). This result is very
similar to the reported value NSC=116 of active stem cells after
bone marrow transplantation in humans [27]. Under normal
physiologic conditions, the active stem cell pool in the cat is
composed of NSC$40 cells [26]. Using the minimum value, the
allometric relation leads to an active pool size of NSC<385 cells for
humans. This result is very similar to estimates based on
Figure 1. Schematic representation of the current understanding of erythropoiesis. Hematopoietic stem cells exist in two distinct compartments: cells
in N2 are actively replicating and contributing to blood cell formation. They are supported by a larger quiescent pool (N1). Cell replication leads to an
exponential amplification (2
K) of progeny that ultimately differentiate into the various types of cells present in the circulation.
doi:10.1371/journal.pone.0000002.g001
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matous disease (CGD) [28]. Furthermore, the present allometric
scaling relation also predicts that one single stem cell is enough to
maintain hematopoiesis for the entire lifespan of a mouse,
consistent with published estimates [21]. The overall consistency
between the predictions based on the allometric relation and
available (though scarce) data for mice, cats and humans suggests
that allometric scaling provides a powerful tool to investigate the
overall properties of the hematopoietic stem cell pool. On the
other hand, such an overall consistency also provides additional
support to the underlying assumptions made in the derivation of
the allometric scaling relation. Extrapolating our data for the pilot
whale (Globicephala macrorhynchus, mass ,2250 kg) we estimate
NSC=4690 whereas for the Asian elephant (Elephas maximus, mass
,6000 kg) NSC=9640 cells, both of which are below the
minimum number (11000) of total stem cells that are thought to
be present in any mammal [19].
According to the Hayflick hypothesis, stem cells replicate a finite
number of times before senescence [29]. Associating the
replication rate of stem cells with RM means the Hayflick
hypothesis is equivalent to state that the lifespan of a stem cell
scales with R{1
M *M
1=4. In the laboratory experiments of Ref.
[26] it was found that stem cells replicate, on average, once every
2.5 weeks in mice and once every 8.3 to 10 weeks in cats (after
transplant). These estimates follow the M
3=4 scaling relation we
derived. Extrapolating these observations to humans, we obtain
a replication rate of once every <20 weeks, significantly lower
than the measurements in Ref. [30] (1 year) or the extrapolation
made in Ref. [26] (42 weeks). Note however that this latter number
was estimated assuming from the outset that stem cells replicate
100 times during the lifetime of a human (80 years). In contrast,
the existence of allometric scaling is the only requirement of our
theory, from which the relevant number can be deduced without
further assumptions. Furthermore, NSC=111 results from allome-
tric scaling for post-transplant conditions, which do not reflect
normal adult hematopoiesis. If we take the allometric prediction
for normal conditions - NSC=385 - then we arrive at a replication
value of approximately once every 60 weeks, close to the results
based on an analysis of telomere shortening in human hemato-
poietic cells [30]. The present estimates are consistent with the
idea that mammals do not exhaust their hematopoietic stem cell
reserve during their lifetime. Indeed, if we assume that a cell
replicates 100 times before senescence, then the lifetime of
a murine stem cell is longer than the lifetime of a mouse,
consistent with the view [21] that a single stem cell may be enough
to maintain hematopoiesis for the entire murine lifespan. In fact,
our present allometric relation predicts that, although larger
mammals require larger active stem cell pools, the expected
lifetime of each species-specific stem cell is always longer than the
expected lifetime of the mammal.
In retrospect, examining the possible explanations invoked in
the beginning of this work, clearly argument (i) was given a precise
allometric justification, whereas (ii) can be ruled out, since it would
contradict the well-established allometric scaling of the specific
BMR [3] which suggests that the rate of replication of cells
decreases as the mass of the mammal increases. Argument (iii)
derives from the Hayflick hypothesis and is supported by our
estimates. The available data does not allow us to elaborate on
argument (iv), but we can state that no special adaptations seem
necessary to explain hematopoiesis in whales or elephants.
A L scaling of NSC has been rationalized in terms of a surface-
to-volume ratio in the four biological dimensions [4,5]. This calls
for detailed studies of the structure-function relationships in the
bone marrow. Indeed, the above scaling is consistent with the
interpretation of the bone marrow as a heterogeneous microen-
vironment in which the active stem cell pool is distributed in
surface niches [31], whereas the quiescent stem cell pool might
presumably occupy the bulk of the bone marrow, in accord with
the prevailing view of the stem cell pool as metaphorically
compartmentalized [22]. As such, detailed studies of bone marrow
physiology may shed light on the mechanisms responsible for the
L scaling relations which pervade in living systems. Finally, the
reduced size of the active stem cell pool in mice, cats and humans
indicates that stochastic effects may play a sizeable role in the
overall dynamics of the hematopoietic system in these mammals.
Such effects will be explored elsewhere [32].
MATERIALS AND METHODS
The total number of circulating reticulocytes was calculated as the
product of the concentration of circulating reticulocytes in the
blood and the blood volume of mature animals for each species. In
Figure 2 we plot the logarithm of RT as a function of the logarithm
of the mass, for mammals that cover over six orders of magnitude.
The range varied from voles with a mass of 20 g up to a pilot
whale with an average mass of 2250 kg. The data corresponds to
the mean value of the reticulocyte count for each species (detailed
minimum and maximum counts are provided in Table S1). The
dashed blue line was obtained from a linear regression, which
leads to an exponent of 0.745<L (R
2=0.94, p,0.0001). The
confidence intervals limit the allometric exponent between 0.70
and 0.76. The intercept of the fitting curve at a mass of 1 gram is
7.641. Hence, we estimate a value of ,10
8 for the reticulocyte
count of the smallest mammal (a shrew with a mass of 3 g).
Figure 2. Allometric scaling of reticulocyte count. We plot the logarithm
of reticulocyte count of a given mammal as a function of the logarithm
of its mass (in gram). Plotted data correspond to a total of 40 mammal
species with masses ranging over 6 orders of magnitude, from voles to
whales. The data corresponds to the mean value of the reticulocyte
count for each species. A straight linear fit leads to a coefficient of 0.745,
remarkably close to the L exponent (R
2=0.94, p,0.0001, CI 0.70–0.76),
with an intercept of 7.641. Hence for the smallest mammal (a shrew
with ,3 gram), we predict a reticulocyte count of ,1610
8.
doi:10.1371/journal.pone.0000002.g002
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Table S1. Upper and lower limit of the logarithm of circulating
reticulocytes across mammals.
Found at: doi:10.1371/journal.pone.0000002.s001 (0.07 MB
DOC)
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